FR940323-1-00070 FR940323-1-00008 XI. Request for Comments Interested persons may, on or before June 21, 1994, submit to the Dockets Management Branch (address above) written comments regarding this proposal. Two copies of any comments are to be submitted, except that individuals may submit one copy. Comments are to be identified with the docket number found in brackets in the heading of this document. Received comments may be seen in the office above between 9 a.m. and 4 p.m., Monday through Friday. List of Subjects in 21 CFR Part 806 Corrections and removals, Medical devices, Reporting and recordkeeping requirements. Therefore, under the Federal Food, Drug, and Cosmetic Act, and under authority delegated to the Commissioner of Food and Drugs, it is proposed that 21 CFR part 806 be added to read as follows: PART 806_MEDICAL DEVICE CORRECTIONS AND REMOVALS Subpart A_General Provisions Sec. 806.1␣Scope. 806.2␣Definitions. Subpart B_Reports and Records 806.10␣Reports of corrections and removals. 806.20␣Records of corrections and removals not required to be reported. 806.30␣FDA access to records. 806.40␣Public availability of reports. Authority: Secs. 502, 510, 518, 519, 520, 701, 704, and 705 of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 352, 360, 360h, 360i, 360j, 371, 374, 375). Subpart A_General Provisions §806.1 Scope. (a) The regulations in this part implement section 519(f) of the Federal Food, Drug, and Cosmetic Act (the act) which requires device manufacturers, distributors, and importers to report promptly to the Food and Drug Administration (FDA) certain actions concerning device corrections and removals, and to maintain records of all corrections and removals regardless of whether such corrections and removals are required to be reported to FDA. (b) The following actions are exempt from the reporting requirements of this part: (1) Actions undertaken by device manufacturers, distributors, and importers to improve the performance or quality of a device which are not intended to reduce a risk to health posed by the device or remedy a violation of the act caused by the device. (2) Routine servicing as defined in §806.2(i). (3) Actions similar to paragraph (b)(1) of this section, undertaken by manufacturers of general purpose articles, such as chemical reagents or laboratory equipment whose uses are generally known by persons trained in their use and which are not labeled or promoted or otherwise intended for medical use. (c) The failure of a manufacturer, distributor, or importer or any person to comply with any applicable requirement of this part renders the device misbranded within the meaning of section 502(t) of the act and further constitutes a prohibited act within the meaning of section 301(q)(1)(B) of the act. §806.2 Definitions. The following terms and definitions apply to this part: (a) Act means the Federal Food, Drug, and Cosmetic Act. (b) Agency or FDA means the Food and Drug Administration. (c) Consignee means any person who received, purchased, or used the device subject to this part. (d) Correction means the repair, modification, adjustment, relabeling, or inspection of a device without its physical removal from its point of use to another location. (e) Distributor means any person, including any person who imports a device into the United States, who furthers the marketing or distribution of a device from the original place of manufacture to the person who makes final delivery or sale to the ultimate user, but who does not repackage or otherwise change the container, wrapper, or labeling of the device or device package. (f) Manufacturer means any person who manufactures, prepares, propagates, compounds, assembles, or processes a device by chemical, physical, biological, or other procedures. The term includes any person who:
